QLERX | VLSCX | QLERX / VLSCX | |
Total Expense Ratio | 5.23 | 3.03 | 173% |
Annual Report Gross Expense Ratio | 5.23 | 3.21 | 163% |
Fund Existence | 11 years | 7 years | - |
Gain YTD | 15.575 | 2.228 | 699% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000000 | 2500 | 2,000,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.96B | 48.4M | 10,242% |
Annual Yield % from dividends | 6.19 | 0.00 | - |
Returns for 1 year | 26.29 | -0.18 | -14,506% |
Returns for 3 years | 79.52 | 15.77 | 504% |
Returns for 5 years | 186.58 | 16.17 | 1,154% |
Returns for 10 years | 158.43 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.07 | -0.41 | -0.63% |
Janus Henderson Global Life Sciences A | |||
VIGIX | 215.36 | -2.91 | -1.33% |
Vanguard Growth Index Institutional | |||
GFCUX | 22.38 | -0.31 | -1.37% |
Goldman Sachs Enhanced U.S. Equity R6 | |||
WBCIX | 15.70 | -0.27 | -1.69% |
William Blair Small-Mid Cap Core I | |||
GTILX | 27.45 | -0.50 | -1.79% |
Glenmede Disciplined USGrEqPtf InstlShrs |